Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15975641 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus
Condition: Sarcoma
Intervention: Drug: topotecan hydrochloride

Indicates status has not been verified in more than two years